Last week, readers were most interested in a story about Lumos Dx's completion of a clinical trial for its FebriDx test and the submission of it for CLIA waiver.

UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other ...

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage ...

NEW YORK – In an effort to expand access to clinical diagnostics in rural and underserved areas, QuidelOrtho recently launched a new program to help deliver instruments to clinical labs. Under the ...

NEW YORK – Sonic Healthcare USA announced Friday that it has acquired substantially all of the assets of Cairo Diagnostics, Cairo Diagnostics NJ, and Rye Management and Logistics. Financial and other ...

The company's laboratory-developed test (LDT) for neurofilament light chain (NfL) also gained New York state approval as part of the permitting process.

WASHINGTON – In a presentation this week at the Next Generation Dx conference here, the National Cancer Institute's Wendy Rubinstein gave an update on the NCI's Vanguard study of multi-cancer early ...

The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.

NEW YORK — The Scottish government has earmarked £800,000 ($1.1 million) to support the introduction of a Genedrive test to help prevent antibiotic-induced deafness in newborns within the country, ...